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Abstract
The aim of this study was to evaluate in vivo whether nitric oxide (NO) is able to diffuse from blood into tissues and vice
versa from tissues into blood. We used an in vivo model of intestinal ischemia (superior mesenteric artery occlusion)
selectively increasing NO levels in intestinal tissue and an infusion of L-arginine selectively increasing NO levels in blood. In
this model we followed formation of nitrosyl complexes of hemoglobin (Hb^NO) in blood and nitrosyl^diethyldithiocarba-
mate^iron complexes (DETC^Fe^NO) in ischemic intestine and normoxic tissues by means of electron paramagnetic
resonance spectroscopy. NO trapping by DETC^Fe in the tissues resulted in a reduction of Hb^NO levels in blood
accompanied by the formation of water-insoluble DETC^Fe^NO complexes in ischemic intestine and normoxic tissues both
during ischemia and during reperfusion. Administration of L-arginine increased NO levels in blood but neither in ischemic
intestine nor in normoxic tissue. Our data suggest that NO released in blood from endothelial cells does not diffuse into
tissue. In contrast, NO formed in tissue diffuses into blood. The latter indicates that NO formed in tissues may exert its
biological activities systematically. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
The major function of nitric oxide (NO) is the
regulation of vascular tonus. Endothelial constitutive
NO synthase (ecNOS) is considered to be the major
source, providing NO for this function. In addition,
NO formed in the blood is believed to di¡use into
cells and in£uence the activity of a number of intra-
cellular enzymes, particularly the respiratory chain.
Some researchers have suggested that NO release
from vascular endothelial cells may play an impor-
tant physiological role in the regulation of tissue mi-
tochondrial respiration [1^4]. High di¡usion coe⁄-
cients of nitric oxide in aqueous solutions [5] as
well as in liposomes and erythrocyte membranes
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[6,7] support this assumption. However, this assump-
tion, which is based almost entirely on in vitro cell
culture models, was contested in the experiments per-
formed with in vivo models. Fish and co-authors
have demonstrated that although NO can reach hep-
atocyte mitochondria in cell cultures, crossing the
aqueous phase and the membranes, in an in vivo
model (LPS-injected rats), NO released into the
blood reacts with Hb without detectable impairment
of mitochondrial function [8]. The absence of impair-
ment of mitochondrial function observed by Fish et
al. indicates that NO cannot di¡use from blood into
tissue in vivo, but direct proof of this has yet to be
attained.
In the meantime knowledge concerning NO me-
tabolism has increased substantially. In particular,
a mitochondrial NOS [9] and intracellular nitrite re-
ductase activities [10,11] have been described for a
number of tissues. NOS-independent intracellular
sources of NO have been found in myocardium
[11,12], skeletal muscles [13], and intestine [14] under
ischemic conditions. These and other data [15] indi-
cate that signi¢cant NO pooling can occur inside
tissue. Obviously, these intracellular NO pools par-
ticipate in the regulation of intracellular functions.
However, it is not clear whether NO coming from
these intracellular NO sources is able to di¡use into
blood and in£uence systemic circulation.
In vivo it is di⁄cult to quantitate NO production
precisely and even more di⁄cult to prove whether
NO has originated from blood or from tissue. The
measurements of the end products of NO oxidation,
nitrite/nitrate, in urine or serum generally re£ect total
body NO production. In blood, however, NO reacts
rapidly with hemoglobin (Hb) to form nitrosyl prod-
ucts (Hb^NO) [16,17] which can be directly measured
with electron paramagnetic resonance (EPR) spec-
troscopy. Inside the tissue and cells where Hb is
not present, the concentrations of NO are measured
after introduction of a speci¢c NO trap. The most
commonly used NO trap is a complex of diethyldi-
thiocarbamate (DETC) and ferrous iron (DETC^Fe)
developed in 1991 [18]. DETC^Fe reacts with NO,
yielding so-called mononitrosyl iron complexes
(DETC^Fe^NO) characterized by a distinct triplet
in the EPR spectrum.
Recently, we have shown that intestinal ischemia
results in increased NO levels in intestine during is-
chemia and in circulating blood during reperfusion
[14]. Therefore the initial aim of this study was to
clarify whether or not there is an exchange between
circulating and intestinal NO pools emerging from
intestinal ischemia/reperfusion. To approach this
aim we used EPR spectroscopy combined with or
without NO-trapping and L-arginine (L-Arg) infu-
sion. The selective stimulation of ecNOS by infusion
of L-Arg, increasing NO levels in blood, is known as
the L-Arg paradox [19] and has been attributed to
down-regulation of ecNOS by endogenous ecNOS
inhibitors. We used this phenomenon in our study
to increase NO levels selectively in blood.
2. Materials and methods
2.1. Animals
Adult male Sprague^Dawley rats weighing 430^
460 g (Animal Research Laboratories, Himberg,
Austria) were used in this study. The study was ap-
proved by the local Committee on Animal Experi-
ments of Vienna, Austria, and all experiments were
performed under the conditions described in the
Guide for the Care and Use of Laboratory Animals
of the National Institutes of Health (publication
NIH 86-23; revised 1985).
2.2. Experimental model
The rats were anesthetized by intramuscular injec-
tion of a mixture of ketamine/xylazine (112:15 mg/kg
body weight) and maintained under anesthesia by
0.2% of iso£urane for the duration of the acute ex-
periment on a temperature-controlled surgical board
(38 þ 1‡C). After performing a midline laparotomy,
the superior mesenteric artery was occluded with an
atraumatic clip applied to the root of the mesentery.
After 60 min of intestinal ischemia, the arterial clip
was removed, allowing reperfusion. The laparotomy
incision was closed, and anesthetized animals under-
went monitoring for 30 min of reperfusion. Similar
to the experimental group, a sham control group
underwent anesthesia and isolation of the superior
mesenteric artery but without being subjected to
the occlusion. A group of animals received L-Arg
(Sigma Chemical Co.), a substrate of NOS, which
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was injected intravenously 10 min prior to ischemia
(100 mg L-Arg/kg body weight) and 5 min prior to
reperfusion (100 mg L-Arg/kg body weight).
2.3. NO trapping and EPR measurements
NO formed in blood was followed by formation of
nitrosyl complexes of hemoglobin (Scheme 1). NO
formed in tissue was trapped, using DETC^Fe
(Scheme 1). To deliver the trap to the tissue 500
mg/kg DETC (Sigma) and 25 mg/kg FeSO4c7H2O
(Sigma) as an iron^citrate complex were injected sep-
arately subcutaneously into the rat with a time inter-
val of 5 min. Occlusion of the mesenteric artery was
performed exactly 20 min after injection of the trap.
A group of animals was treated in the same manner,
but without introduction of the NO trap. The sam-
ples were placed in 1-ml syringes (B. Braun Melsun-
gen) and frozen in liquid nitrogen. Then the samples
were pressed out of the syringes and moved to a
¢nger-tip liquid nitrogen dewar for EPR measure-
ments. The EPR spectra were recorded at liquid ni-
trogen temperature with a Bruker EMX EPR spec-
trometer (the general settings were: microwave
frequency 9.431 GHz, modulation frequency 100
kHz, microwave power 20 mW, modulation ampli-
tude 4 G; gain 105). In the same samples EPR signals
of methemoglobin (metHb) at g = 6.0 were detected
at the following instrumental conditions: microwave
frequency 9.431 GHz, modulation frequency 100
kHz, microwave power 20 mW, modulation ampli-
tude 20 G; time constant 0.16 s, scan time 1000G/84
s, gain 105.
In order to quantify NO levels in blood, the dou-
ble integrals of Hb^NO signals were calculated and
compared with those obtained from Hb^NO stan-
dards. The preparation of Hb^NO standards was
performed as described earlier [20]. For this purpose
distilled water saturated with NO was taken as a
standard solution of 2 mM according to the solubil-
ity of NO in water and mixed with Hb solutions
under anaerobic conditions. Hb solutions were pre-
pared from rat red blood cells and quanti¢ed as de-
scribed previously [21]. Commercial (Sigma) metHb
(10^30 WM in 20 mM PBS, pH 7.4) was used to
quantify metHb signals.
2.4. Statistics
Statistical parameters were calculated using analy-
sis of variance (Excel 5.0 software, Microsoft),
3. Results
Analyzing the EPR spectra of plasma and red
Scheme 1. Illustration of EPR technique combined with the
double trapping of nitric oxide in vivo. NO formed in blood re-
acts with hemoglobin to form nitrosyl complexes of hemoglo-
bin. These complexes are very stable and may circulate in blood
for hours. Hb^NO complexes have a characteristic EPR signal
(signal a), which allows qualitative and quantitative analysis of
NO bound to Hb. We measured NO levels in tissue using di-
ethyldithiocarbamate^iron complex (DETC^Fe), a water-insolu-
ble NO trap. To deliver this trap to tissue two water-soluble
components of the trap, DETC (500 mg/kg) and FeSO4 (25
mg/kg) as an iron^citrate complex (1:4 M/M), were injected
subcutaneously separately into the rat with a time interval of
5 min. In tissue these components form an insoluble DETC^
Fe(2+) complex, which traps NO yielding DETC^Fe^NO com-
plex. The latter is also water-insoluble, remaining in a tissue
where it was formed. DETC^Fe^NO complex has a characteris-
tic EPR signal (signal b) which allows qualitative and quantita-
tive analysis. Blood and tissue were frozen in liquid nitrogen
immediately after withdrawal. EPR measurements were also
performed at liquid nitrogen temperature.
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blood cells of the animals subjected to intestinal is-
chemia/reperfusion we could detect DETC^Fe^NO
complexes neither in plasma nor in red blood cells
in the presence of DETC^Fe (Fig. 1). Regardless of
whether DETC^Fe was present or not, only Hb^NO
complexes were detectable in blood. In contrast, a
pronounced EPR signal of DETC^Fe^NO was ob-
served in tissue only when the NO trap was present
(Fig. 1).
Since Hb cannot di¡use through cell membranes it
clearly does not trap NO inside tissue cells. As for
DETC^Fe, it is de¢nitely transported to the tissue
with the blood, and consequently the blood is ex-
pected to contain DETC^Fe. However, DETC^Fe^
NO complexes were not detectable in the blood. In
an attempt to clarify this, we treated serum and red
blood cells with NO, in order to develop the total
amount of NO traps present. Upon addition of 1 mM
NO (as a NO solution) to red blood cell suspension
of the animals subjected to intestinal ischemia/reper-
fusion, only a strong Hb^NO signal appeared in the
EPR spectrum (Fig. 2). The addition of the same
amount of NO to the plasma obtained from the
same animal resulted in a weak signal of DETC^
Fe^NO complexes (Fig. 2). The addition of dithion-
ite, a strong reducing agent, resulted in a drastic in-
crease of the DETC^Fe^NO signal magnitude in re-
sponse to NO (Fig. 2). These results indicate that
NO trap is abundantly present in plasma in an in-
active form, which can be activated in the presence of
a reducing agent. Probably this indicates that the
main part of iron in DETC^Fe complex is present
in ferric form. Only a small portion of NO trap
(6 10%) was present in plasma in an active form.
However, it did not trap NO, probably because the
Hb also present traps NO more e⁄ciently.
Fig. 1. EPR spectra observed in blood and tissue of animals subjected to intestinal ischemia (1 h) and reperfusion (0.5 h). The left
panel shows typical EPR spectra observed in tissue of animals subjected to ischemia/reperfusion without NO trap. The right panel
shows typical EPR spectra observed in tissue of animals subjected to ischemia/reperfusion and additionally receiving NO trap, DETC
and Fe^citrate. Hb^NO, NO^Fe^DETC, and Cu^DETC indicate characteristic features of corresponding EPR signals. The spectra
were obtained using the following instrument parameters: microwave frequency 9.431 GHz, modulation frequency 100 kHz, micro-
wave power 20 mW, modulation amplitude 4 G; time constant 0.66 s, scan time 300G/336 s, gain 105.
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Since DETC^Fe^NO complex is water-insoluble,
one can expect the mobility of NO bound to
DETC^Fe to be reduced. If increased circulating lev-
els of Hb^NO during ischemia/reperfusion are due to
NO di¡used from tissue, the presence of DETC^Fe,
trapping NO, should reduce the rate of the NO dif-
fusion into blood and consequently reduce circulat-
ing Hb^NO levels. To clarify this point we followed
Hb^NO levels in blood in an additional group of
animals subjected to intestinal ischemia/reperfusion
without receiving NO trap. In this group Hb^NO
levels were already increased during ischemia and
even more so during reperfusion (Fig. 3). The pres-
ence of NO trap resulted in a signi¢cant decrease in
Hb^NO levels both during ischemia and during re-
perfusion. Strong reduction of the Hb^NO levels in
blood in the presence of DETC^Fe (Fig. 3) indicates
that NO can di¡use from tissue to blood.
To prove whether NO may di¡use in the opposite
direction from blood into tissue, we stimulated NO
formation by ecNOS infusing L-Arg into the vena
cava of rats subjected to intestinal ischemia/reperfu-
sion. After 0.5 h of reperfusion L-Arg elevated only
the levels of Hb^NO in blood but did not in£uence
DETC^Fe^NO levels in tissue (Fig. 4). Thus, NO
derived from ecNOS, being bound to Hb, does not
di¡use into cells.
Apart from the binding to hemoglobin, NO may
undergo an oxidative reaction with oxyhemoglobin
involving formation of metHb and nitrate. The mea-
surements of metHb were made in the same samples
as Hb^NO complexes following high-spin iron sig-
nals at g = 6.0 (Fig. 5, inset). A signi¢cant increase
in metHb levels was observed at 30 min of reperfu-
sion (Fig. 5). Infusion of L-Arg elevated metHb levels
while omission of NO trap had no e¡ect on metHb
levels (Fig. 5).
Fig. 3. Blood circulatory levels of Hb^NO complexes in sham-
operated rats and rats subjected to intestinal ischemia (1 h) and
reperfusion (0.5 h). Ischemia was induced by occlusion of supe-
rior mesenteric artery for 1 h. Sham-operated animals were
treated the same as those in the experimental group, but with-
out artery occlusion. One group (hatched bars) of animals re-
ceived NO trap (DETC plus iron^citrate) and the other group
(open bars) did not. #P6 0.002 vs. sham; P6 0.002 vs. the
group without NO trap.
Fig. 2. EPR spectra of rat Hb solutions and serum samples ob-
tained from the animals subjected to 1 h ischemia and 0.5 h re-
perfusion and receiving NO trap, DETC and iron^citrate com-
plex. A, 0.3 mM Hb solution in 50 mM PBS (pH 7.4) mixed
with water (1:1 v/v). B, Hb solution as in A mixed with 2 mM
NO solution (1:1 v/v). Hb and NO solutions were prepared as
described in Section 2. C, serum obtained from the animals
subjected to 1 h ischemia and 0.5 h reperfusion and mixed with
water (1:1 v/v). D, serum as in C mixed with 2 mM NO solu-
tion (1:1 v/v). E, serum mixed with NO solution as in C, con-
taining additionally 5 mg/ml dithionite. The instrumental pa-
rameters were as described in Fig. 1.
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4. Discussion
To characterize the exchange between circulating
and intracellular NO pools we used an in vivo model
of intestinal ischemia selectively increasing NO levels
in intestinal tissue, and infusion of L-Arg selectively
increasing NO levels in blood. In this model we have
shown that only Hb traps NO in blood and only
DETC^Fe traps NO in tissue (Figs. 1 and 2). The
former results in a formation of Hb^NO complexes
and the latter yields DETC^Fe^NO complexes. Both
complexes have well distinguishable EPR signals.
Thus, we followed formation of Hb^NO and
DETC^Fe^NO complexes to characterize the origin
of NO. We observed that trapping NO in tissue by
DETC^Fe reduces the level of Hb^NO complexes in
blood during ischemia and reperfusion (Fig. 3). This
reduction of circulating Hb^NO levels was accompa-
nied by formation of water-insoluble DETC^Fe^NO
complexes in tissue. The fact that a decrease in Hb^
NO concentrations was observed during ischemia in-
dicates that NO di¡uses into blood not only from
intestine during reperfusion but also from normoxic
tissue, while intestine is isolated from circulation.
Administration of L-Arg increased NO levels in
blood but not in tissue (Fig. 4). This could have
di¡erent explanations: (i) intracellular NOS are not
limited by L-Arg concentration; (ii) L-Arg does not
di¡use into cells in our model; (iii) tissue NO does
not originate from L-Arg; (iv) the amount of NO
di¡used into the tissue is too small to in£uence intra-
cellular NO levels; (v) so-called L-Arg paradox [19]
does not occur in tissues other than endothelial cells.
Regardless of which of those explanations is correct,
the fact that L-Arg selectively increased NO levels in
blood but neither in ischemic intestine nor in nor-
moxic tissue clearly shows that NO does not di¡use
from blood to tissue. This is in line with the results of
Fish and co-authors [8], demonstrating that in blood
NO rapidly reacts with sinusoidal hemoglobin with-
Fig. 5. MetHb formation during ischemia reperfusion, e¡ect of
L-Arg and NO trap. MetHb concentration was estimated by
measuring the EPR signal intensity of high-spin heme iron
(g = 6.0) in the same samples as for detection of Hb^NO com-
plexes. The spectra were obtained using the following instru-
ment parameters: microwave frequency 9.431 GHz, modulation
frequency 100 kHz, microwave power 20 mW, modulation am-
plitude 20 G; time constant 0.16 s, scan time 1000G/84 s, gain
105. #P6 0.0004 vs. sham; P6 0.02 vs. the group without NO
trap, after 0.5 h of reperfusion.
Fig. 4. E¡ect of L-Arg infusion on NO levels in blood (as de-
tected by formation of Hb^NO complexes) and tissue (as de-
tected by formation of DETC^Fe^NO complexes) after 1 h of
intestinal ischemia and 30 min of reperfusion. All animals re-
ceived NO trap, DETC and Fe^citrate. The average value of
NO-related signal (Hb^NO or DETC^Fe^NO) in a group with-
out L-Arg (I/R+DETC^Fe, open bars) was taken as 100%.
Then NO levels in a group receiving L-Arg (I/R+DETC^Fe+
L-Arg, hatched bars) was expressed as percent to NO level in
the group without L-Arg (% to I/R+DETC^Fe). Thus, the data
can be compared only within one tissue. #P6 0.0002 vs. blood
in the group without L-Arg.
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out detectable impairment of hepatic mitochondrial
function.
Apart from the high binding a⁄nity of NO to
hemoglobin, the oxidative reaction between NO
and oxyhemoglobin needs to be taken into consider-
ation. We detected this reaction following metHb
formation. It is interesting to compare our data
with recent results on NO inhalation published by
Gladwin et al. [22] This article demonstrates that
NO inhalation results in an almost identical increase
in both Hb^NO and metHb in blood. These data
indicate that ‘binding’ and ‘oxidative’ pathways are
equally sensitive to increased NO concentrations dur-
ing NO inhalation. In our ischemia/reperfusion mod-
el we observed a more modest increase in metHb
levels (Fig. 5) and a rather strong increase in the
levels of Hb^NO levels (Fig. 3) as compared to their
control values. The infusion of L-Arg elevated both
Hb^NO and metHb levels while omission of NO trap
resulted only in an increase in Hb^NO levels. This
discrepancy, however, can be understood if we con-
sider that oxygen may trigger ‘oxidative’ and ‘bind-
ing’ pathways. Indeed, in Gladwin’s model NO re-
acts with Hb in the lung where oxygen tension is
high. Therefore, NO inhalation results in a pro-
nounced activation of the ‘oxidative’ pathway. In
our study we used L-Arg to stimulate NO generation
in all vessels including those near the lung. There-
fore, L-Arg induced modest activation of ‘oxidative’
pathway (Fig. 5). In contrast, an additional release of
NO from tissue induced by omission of NO trap
takes place in the capillary bed where oxygen tension
is low. Therefore, the release of NO at this site does
not signi¢cantly activate the ‘oxidative’ pathway
(Fig. 5).
A similar question can be addressed to intracellu-
lar compartments as well. In intracellular compart-
ments NO may also follow the ‘oxidative’ pathway
and be dioxygenased by myoglobin, for example, as
has been shown for a number of bacterial hemoglo-
bins [23]. However, dioxygenase activity requires
oxygen. Thus, the oxidative pathway is not likely
to in£uence accumulation of NO during ischemia
but may explain the decrease in tissue NO levels
during reperfusion observed in our recent study [14].
This discussion raises a fundamental question re-
garding the markers of in vivo production and bio-
logical activity of NO. In this respect the data pub-
lished recently by Dohrlty [24] are of interest. Using
recombinant hemoglobins, the authors have shown
that the ‘oxidative’ pathway is dominant in biologi-
cal e¡ects of NO (e.g., blood pressure) while Hb^NO
complexes were considered too stable to deliver rea-
sonable amounts of NO to the tissues. Consequently,
the latter may be considered as a good marker of in
vivo NO production.
In general, our data suggest that NO formed by
ecNOS is not able to in£uence intracellular NO levels
or to regulate intracellular functions (e.g., respira-
tion, which is sensitive to the presence of NO).
The fact that NO formed in tissue is able to di¡use
into blood suggests that intracellular NO pools
may in£uence circulation parameters. Additionally,
described results may have also an important patho-
physiological signi¢cance. In particular, the stimula-
tion of intracellular sources of NO (such as mito-
chondrial NOS, intracellular nitrite reductase ac-
tivity) may in£uence circulatory parameters. This
phenomenon could be of particular interest under
circumstances accompanied by ischemia or hypoxia
when there is a strong need to improve microcircu-
lation.
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